Cytek CTO’s $4.71 M Sale Highlights Insider Liquidity Strategy Amid Market Pullback
Cytek Biosciences CTO Yan Ming sells 1.18 M shares—largest insider sale in a week—yet execs keep buying. Insight into liquidity moves, market impact and investor clues.
3 minutes to read